CID 161731

Dtxsid8067652

Structural Information

Molecular Formula
C22H21N3O4S2
SMILES
CCN1C2=CC=CC=C2SC1=CC(=C3C(=NN(C3=O)C4=CC=C(C=C4)S(=O)(=O)O)C)C
InChI
InChI=1S/C22H21N3O4S2/c1-4-24-18-7-5-6-8-19(18)30-20(24)13-14(2)21-15(3)23-25(22(21)26)16-9-11-17(12-10-16)31(27,28)29/h5-13H,4H2,1-3H3,(H,27,28,29)
InChIKey
BGUFNHOQYFNSKN-UHFFFAOYSA-N
Compound name
4-[4-[1-(3-ethyl-1,3-benzothiazol-2-ylidene)propan-2-ylidene]-3-methyl-5-oxopyrazol-1-yl]benzenesulfonic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

1
Patents

455.09735 Da
Monoisotopic Mass

4.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 456.10463 210.1
[M+Na]+ 478.08657 219.8
[M-H]- 454.09007 216.6
[M+NH4]+ 473.13117 220.2
[M+K]+ 494.06051 212.4
[M+H-H2O]+ 438.09461 204.5
[M+HCOO]- 500.09555 215.8
[M+CH3COO]- 514.11120 225.1
[M+Na-2H]- 476.07202 204.7
[M]+ 455.09680 214.1
[M]- 455.09790 214.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe